New biologic patch aims to keep knees in place after first dislocation
NCT ID NCT06169800
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study tests whether adding a biologic scaffold (Biobrace®) to standard ligament repair surgery can reduce the chance of the kneecap dislocating again. The study will enroll 20 people aged 13 to 30 who have had a first-time lateral patellar dislocation within the past week. Researchers will compare the re-dislocation rate to the expected 30% rate seen with non-surgical care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Biobrace® biologic ligament augment (device used during MPFL repair surgery)
- What this could lead to
- If successful, this could offer a minimally invasive surgical option to lower the chance of repeat knee dislocation after a first-time injury.
- What could go wrong
- This is a very small pilot study with only 20 people, so results may not apply to everyone. The device is new and its long-term safety and effectiveness are not yet proven.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PATELLOFEMORAL DISLOCATION are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Banff Sport Medicine
RECRUITINGCanmore, Alberta, T1W 0L5, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.